Clinical Trial Update: A Study of REGN7544 for the Treatment in Adult Patients With Sepsis-Induced Hypotension [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for REGN7544 in adults with sepsis-induced hypotension; the study is currently ACTIVE_NOT_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sepsis

Drugs mentioned

• REGN7544

Snippet

Sponsor: Regeneron Pharmaceuticals | Conditions: Sepsis-Induced Hypotension | Phase 2 | Status: ACTIVE_NOT_RECRUITING